Literature DB >> 16006966

Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization.

Jimsgene Sanjmyatav1, Nikolai Rubtsov, Heike Starke, Joerg Schubert, Winfried Hindermann, Kerstin Junker.   

Abstract

PURPOSE: We developed a rapid interphase fluorescence in situ hybridization (FISH) test to differentiate renal cell carcinoma (RCC) based on known genetic alterations and verified the suitability of this test for practical use.
MATERIALS AND METHODS: We composed 2 FISH test sets using 6 centromere specific and 2 region specific DNA probes of human chromosomes. Test set 1 contained centromeric probes for chromosomes 1, 2, 6 and 9, as labeled by 4 fluorescence dyes. For test set 2 we chose 3p24pter and 3p13p14 regions, and centromeric probes of chromosomes 7 and 17. Interphase nuclei of tumor specimens were prepared from 50 mum frozen tissue sections and fixed on slides. The 2 sets were hybridized simultaneously side by side on the same slide.
RESULTS: Seven clear cell carcinomas, 8 papillary carcinomas, 7 chromophobe RCCs and 3 oncocytomas were analyzed by interphase FISH. Results were compared with comparative genomic hybridization findings and pathological reports. Genetic alterations were detected in 22 of 25 analyzed tumors by FISH. FISH findings absolutely correlated with comparative genomic hybridization results. Of the analyzed carcinomas 22 could be identified correctly. In 3 tumors the histological subtypes were revised.
CONCLUSIONS: The results of this study demonstrate that the performed test set allows the accurate identification of RCC in 1 hybridization step. Therefore, FISH represents an effective method for the rapid classification of RCC.

Entities:  

Mesh:

Year:  2005        PMID: 16006966     DOI: 10.1097/01.ju.0000166749.38455.bc

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses.

Authors:  Aliaksei Chyhrai; Jimsgene Sanjmyatav; Mieczyslaw Gajda; Olaf Reichelt; Heiko Wunderlich; Thomas Steiner; Enis Tanović; Kerstin Junker
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

2.  [Personalized urooncology based on molecular uropathology: part 1: what is diagnostic routine?].

Authors:  C G Stöhr; R Stöhr; A Rogler; K Amann; R Knüchel-Clarke; A Hartmann
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

3.  Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.

Authors:  Ana Sílvia Pires-Luís; Márcia Vieira-Coimbra; Filipa Quintela Vieira; Pedro Costa-Pinheiro; Rui Silva-Santos; Paula C Dias; Luís Antunes; Francisco Lobo; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Chromophobe renal cell carcinoma with prominent lymph node metastasis and polysomy of chromosome 21: poorly differentiated form or "presarcomatoid" form?

Authors:  Naoto Kuroda; Masato Tamura; Ondrej Hes; Michal Michal; Taro Shuin; Makoto Toi; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

5.  [Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].

Authors:  K Junker; T Steiner; J Sanjmyatav; R Pilchowski; C Heinze; M Walter; J Schubert
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

6.  End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Authors:  Ondrej Hes; Radek Síma; Jana Nemcová; Milan Hora; Stela Bulimbasic; Dmitry V Kazakov; Tomás Urge; Tomás Reischig; Miroslav Dvorák; Michal Michal
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

7.  [Renal cell carcinoma 2008. Histopathology, molecular genetics and new therapeutic options].

Authors:  C G Hammerschmied; B Walter; A Hartmann
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

8.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

Review 9.  [Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].

Authors:  K D Mertz; J Tchinda; R Küfer; P Möller; M A Rubin; H Moch; S Perner
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

10.  Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH.

Authors:  J Sanjmyatav; S Matthes; M Muehr; D Sava; M Sternal; H Wunderlich; M Gajda; M-O Grimm; K Junker
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.